Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 17635389.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated following the second consensus conference in Stockholm in 2005. It is hoped that these guidelines will continue to help researchers in the field and assist the pharmaceutical industry and equipment manufacturers in enhancing the standards of the studies they sponsor.
Medical subject headings
- Clinical Trials as Topic
- Neuromuscular Blocking Agents